What You Should Know:
– Florida Cancer Specialists & Research Institute (FCS), a leading provider of comprehensive cancer care, has announced a new partnership with Paradigm Health, a technology platform specializing in clinical trial management.
– The collaboration aims to expand patient access to innovative treatments through more efficient clinical trial recruitment and execution.
A Strategic Partnership for Enhanced Clinical Trial Access
FCS has experienced steady growth in its clinical trial offerings, with over 600 patients participating annually. By partnering with Paradigm, FCS will leverage the platform’s powerful technology to streamline the planning, recruitment, and conduct of clinical trials across its 33 research locations. This will enable FCS to offer patients more opportunities to participate in cutting-edge clinical trials and potentially access life-saving therapies.
Paradigm’s Technology Platform
Paradigm’s platform provides a seamless solution for healthcare providers and trial sponsors, streamlining the process of conducting clinical trials. The platform offers features such as:
- Efficient trial planning: Streamlined workflows and data management tools to optimize trial design and execution.
- Enhanced patient recruitment: Advanced tools for identifying and engaging potential trial participants.
- Improved collaboration: Enhanced communication and collaboration between healthcare providers, trial sponsors, and patients.
“Our shared missions align perfectly in this partnership to increase access to cutting-edge treatments that are often only available through trials,” said Kent Thoelke, CEO of Paradigm. “Paradigm’s platform will allow FCS to screen every single patient for clinical trial eligibility and then streamline recruitment and participation – without adding to the work burden of clinical teams. We’re honored to bring global biopharma trials directly to Florida Cancer Specialists & Research Institute, reinforcing their leadership in cancer care in Florida.”
